Discover 1,928 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,928
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Location: Dallas TX
Sponsor: Secretome Therapeutics
Sex: All
Age: 18+
Code: NCT06560762
Phase1, Recruiting
PK(Pharmacokinetic) Papyrus Covered Coronary Stent System
for
Coronary Disease
Location: Dallas TX
Sponsor: Methodist Health System
Sex: All
Age: 0+
Code: NCT06223633
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Dallas TX, Houston TX, Columbus OH, Canton OH,
Sponsor: OncoNano Medicine, Inc.
Sex: All
Age: 18+
Code: NCT06022029
Phase1, Recruiting
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
for
Overactive Bladder (OAB), Urinary Urgency,
Location: Dallas TX, Birmingham AL, Chicago IL, Madison WI,
Sponsor: Medstar Health Research Institute
Sex: Female
Age: 22+
Code: NCT06797245
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib
for
Langerhans Cell Histiocytosis
Location: Fort Worth TX
Sponsor: Cook Children's Health Care System
Sex: All
Age: 1 - 30
Code: NCT06582745
Phase2, Recruiting
A Multicenter Breast Cancer Biospecimen Registry
for
Breast Cancer
Location: Dallas TX, Redding CA
Sponsor: Luminist, Inc.
Sex: Female
Age: 40+
Code: NCT02712645
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Location: Fort Worth TX, Houston TX, San Antonio TX, Mobile AL,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0 - 1
Code: NCT05685745
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
for
Crohn's Disease
Location: Fort Worth TX, Atlanta GA, Indianapolis IN, Dayton OH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 2 - 17
Code: NCT05509777
Phase3, Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Dallas TX, The Woodlands TX, Houston TX, Alexandria LA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase3, Recruiting
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
for
Liver Fibroses, Cirrhosis
Location: Dallas TX, Boston MA
Sponsor: Raymond Chung
Sex: All
Age: 18+
Code: NCT05028829
Phase2, Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Plano TX, Dallas TX, Bartlesville OK, Austin TX,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase3, Recruiting
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
for
Prostate Cancer, Prostate Adenocarcinoma
Location: Dallas TX, Chicago IL, Portland OR
Sponsor: University of Chicago
Sex: Male
Age: 18+
Code: NCT05726292
Phase2, Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohn Disease
Location: Dallas TX, Tyler TX, Cedar Park TX, Bellaire TX,
Sponsor: Abivax S.A.
Sex: All
Age: 18 - 70+
Code: NCT06456593
Phase2, Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne